Efficacy and safety of Lian-Hua Qing-Wen granule for COVID-2019: A protocol for systematic review and meta-analysis
Conclusion:
Our study aims to systematically present the clinical evidence of LHQWG in treating COVID-19, which will be of significant meaning for further research and clinical practice.
OSF registration number:
10.17605/OSF.IO/27SBU.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: China Health | Coronavirus | COVID-19 | Internal Medicine | Outbreaks | Pandemics | Respiratory Medicine | SARS | Study